InsidersTradesSigma
Track the IME stock price and the full insider trade history of the company, a listed equity based in Australia. Shares trade on the AU market, under the authority of ASX. Operating in the Health Care sector, IME has logged 2 public disclosures. Market capitalisation: €17.4m. The latest transaction was reported on 12 June 2026 (Sale). Among the most active insiders: Damian Banks. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
IME is a company operating in the health and pharmaceutical sector, listed on the XASX. It focuses on developing innovative solutions to enhance healthcare.